Inhalat

Salbutamol Sulfate, the active ingredient in Inhalat, is a beta2‑adrenergic agonist presented as an inhalation product for inhalation use. It delivers rapid bronchodilation to relieve airway narrowing in patients with asthma and chronic obstructive pulmonary disease (COPD) as directed by a healthcare professional. The formulation is designed for handheld inhaler devices and provides quick symptom control during acute episodes. The product conforms to EU regulatory standards and is manufactured under strict quality controls.

GNH USA supplies Inhalat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inhalat, containing salbutamol sulfate, is a short‑acting bronchodilator that acts on the beta2‑adrenergic pathway to relieve airway obstruction.

Asthma: provides rapid relief of bronchospasm and improves airflow during acute attacks. COPD: reduces dyspnea and improves exercise tolerance in patients with chronic obstructive pulmonary disease. Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity in susceptible individuals.

Inhalat may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Tremor or shaking of the hands - Headache - Palpitations or rapid heartbeat - Nervousness or anxiety - Throat irritation or cough - Dry mouth

Serious or Rare Side Effects: - Paradoxical bronchospasm (worsening of breathing) - Significant cardiac arrhythmia or tachycardia - Severe hypokalemia (low blood potassium) - Anaphylactic or severe allergic reaction

When prescribing or using Inhalat, several precautions should be observed to ensure safe and effective therapy.

Assess severity: evaluate asthma or COPD severity before initiating therapy. Cardiovascular monitoring: observe heart rate and blood pressure, especially in patients with cardiac disease. Use with caution in hypokalemia: monitor serum potassium levels if patient is on diuretics. Avoid excessive dosing: follow prescriber instructions to prevent tachyphylaxis. Store at ambient temperature: keep in original container, protect from moisture and direct heat.

Inhalat can interact with other medicines; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol) may blunt bronchodilator effect. - Monoamine oxidase inhibitors (MAOIs) can increase cardiovascular stimulation. - High‑dose thiazide diuretics may exacerbate hypokalemia.

Moderate Interactions (Monitor Closely): - Theophylline may increase risk of cardiac side effects. - ACE inhibitors can potentiate hypotensive effects. - Loop diuretics may further lower potassium levels.